
http://www.nlm.nih.gov/medlineplus/tutorials/h1n1flu/htm/index.htm
Dr Marwah
Admissibility / Entitlement for traveling by Shatabadl Express
No.19030/3/2008-E.IV
Government of India
Ministry of Finance
Department of Expenditure
.........
NewDelhi,Dated 29th June,2009.
OFFICE MEMORANDUM
Subject:- Admissibility / entitlement for traveling by Shatabadl Express.
.........
The undersigned is directed to refer to para 2 A of Annexure to this Department's OM of even number dilled 23.9.2008 and to clarify that for the purpose of journeys on tour, officers drawing Grade Pay of Rs.7600 and above are entitled to travel by Executive Class in Shatabadi trains and AC First Class In Rajdhani trains.
--
Dr Marwah
CENTRAL GOVERNMENT EMPLOYEES NEWS |
Posted: 24 Jul 2009 07:31 PM PDT No. 13018/1/2009-Estt.(L) GOVERNMENT OF INDIA Ministry of Personnel, Public Grievances & Pensions (Department of Pension & Pensioners'Welfare) Lok Nayak Bhawan,New Delhi-110003 OFFICE MEMORANDUM Sub: Enhancement of Child Adoption Leave from 135 days to 180 days and extension of the facility of Paternity Leave to adoptive fathers. The undersigned is directed to refer to this Department's O.M. No.13018/4/2004-Estt.(L) dated 31st March, 2006 regarding grant of Child Adoption Leave for 135 days to female Government servant on adoption of a child upto the age of one year, on the lines of maternity leave admissible to natural mothers. After implementation of the Sixth Central Pay Commission recommendations, the period of maternity leave was enhanced from 135 days to 180 days. Subsequently, this Department has received representations requesting for enhancement of the period of Child Adoption Leave from 135 days to 180 days in line with the maternity leave. The matter has been examined in this Department and it has been decided to enhance the period of Child Adoption Leave from 135 days to 180 days. 2. A female Government servant in whose case the period of 135 days of Child Adoption Leave has not expired on the date of issue of these orders shall also be eligible for Child Adoption Leave of 180 days. 3. It has also been decided that a male Government servant (including an apprentice) with less than two surviving children, on valid adoption of a child below the age of one year, may be sanctioned Paternity Leave for a period of 15 days within a period of six months from the date of valid adoption. 4. These orders shall take effect from the date of issue. 5. In so far as persons serving in the Indian Audit and Accounts Department are conceded, these orders issue in consultation with the Comptroller and Auditor General of India. this is a test message |
You are subscribed to email updates from CENTRAL GOVERNMENT EMPLOYEES NEWS To stop receiving these emails, you may unsubscribe now. | Email delivery powered by Google |
Inbox too full? | |
Google Inc., 20 West Kinzie, Chicago IL USA 60610 |
https://www.benfotiamine.net/ShoppingCart.aspx?Category=0
Vitamer EA is benfotiamine a dietary supplement
3. HAVE THERE BEEN RECENT CLINICAL TRIALS USING BENFOTIAMINE?
4. HOW ABOUT INTERACTIONS WITH OTHER MEDICATIONS?
5. WHAT TYPE OF CONDITIONS MAY RESPOND WELL TO BENFOTIAMINE?
6. HOW MUCH BENFOTIAMINE SHOULD I USE DAILY?
7. WHAT IS THE FDA POSITION ON BENFOTIAMINE?
8. WHY HAVEN'T I HEARD OF BENFOTIAMINE BEFORE?
9. WHAT DOES "PHARMACEUTICAL GRADE" MEAN?
10. HAVE YOU RECEIVED ANY TESTIMONIALS?
11. WHERE CAN I BUY BENFOTIAMINE?
Benfotiamine is a lipid-soluble form of thiamine (vitamin B-1). It is perhaps the most effective of the allithiamine group of naturally occurring, thiamine-derived compounds, found in trace quantities in roasted crushed garlic and other vegetables from the Allium genus (such as onions, shallots, and leeks). The best description of benfotiamine I have found was assembled by AOR, a Canadian nutriceutical company: Abstracts & Summary Description of Benfotiamine. If you are interested in the benfotiamine molecule, you may view it here: Benfotiamine Molecule. You may also view the original U.S. patent for benfotiamine here: Adobe Version of Benfotiamine Patent.
Though benfotiamine is lipid-soluble, it metabolizes quickly, producing high levels of thiamine pyrophosphate (TPP, the active form of thiamine), which then continues to metabolize in the body as usual. Benfotiamine itself does not accumulate in the body. The original patent filed in the United States on benfotiamine, Adobe Version of Benfotiamine Patent, included data from LD-50 tests on lab mice (Table III) indicating that benfotiamine is significantly less toxic than common vitamin B-1 (typically, thiamine hydrochloride). Thiamine hydrochloride has been the subject of much research. To quote from the European Commission Health and Consumer Protection Directorate General study on the tolerable upper intake level of vitamin B-1, paragraph 3. Hazard Identification:
"3.1. Evidence of adverse effects in humans. Orally ingested vitamin B1 has a long history of use as an oral supplement without reported adverse effects. Due to its therapeutic action in some frequently observed clinical syndromes, thiamine hydrochloride has been advised and used over a long period of time. There are no reports of adverse effects of oral thiamine, even at dosages of several hundred milligrams a day (SCOGS, 1978; DHEW, 1979; Marks, 1989)."
The entire EC study is available at: Tolerability of Thiamine (Vitamin B-1). Again, vitamin-B-1 has proven safe after decades of public use and benfotiamine has been found to be significantly more tolerable than common vitamin B-1. Also, there are no known negative interactions between benfotiamine and other supplements or medications. However, there is information published by Ohio State University in 1996 and by the European Journal of Biochemistry in 2001 indicating thiamine supplementation should be carefully considered in patients undergoing therapy for tumorous forms of CANCER. These articles address thiamine in general (not specifically benfotiamine) but I find them relevant since benfotiamine is essentially a very effective form of thiamine. You may access that information here: OSU Article, EJB Abstract.
Otherwise, I believe there is minimal to nil downside in trying benfotiamine and the individual results have the potential to be quite significant. Still, it is wise and prudent to consult your health care provider before beginning a benfotiamine regimen. Also, if you have a known sensitivity to thiamine, you should check with your health care provider before using benfotiamine.
3. HAVE THERE BEEN RECENT CLINICAL TRIALS USING BENFOTIAMINE?
Yes, in the past couple of years interest in this compound has grown significantly. You may link to some of the recent clinical trial abstracts here: Clinical Trials.
4. HOW ABOUT INTERACTIONS WITH OTHER MEDICATIONS?
Benfotiamine has no known negative interactions with any medications. In fact, the use of some medications may cause a thiamine deficiency which benfotiamine would likely correct: Interactions.
5. WHAT TYPE OF CONDITIONS MAY RESPOND WELL TO BENFOTIAMINE?
While the recent clinical trials have concentrated on conditions such as neuropathy, retinopathy and nephropathy, there is an expectation among those studying this compound that its beneficial effects may be far more wide-ranging, to include: sciatica, vascular health, general nerve health, improved blood pressure, general cellular protection, anti-aging, fibromyalgia, prevention of lactic acidosis, and treatment for Alzheimer's disease. A most informative link on this topic is: Abstracts & Summary Description of Benfotiamine.
Benfotiamine is not just for diabetics. Any condition that is the result of a thiamine deficiency will likely respond quite well to benfotiamine. Of course, any bodily function that is improved by a therapeutic level of thiamine would most likely be enhanced by benfotiamine, since benfotiamine is perhaps the most effective form of thiamine. Some interesting facts regarding thiamine can be found at this link: Thiamine Facts. More on thiamine can be found here: More Thiamine Facts.
6. HOW MUCH BENFOTIAMINE SHOULD I USE DAILY?
Though the body cannot use more than about 10mg. of common, water-soluble vitamin B-1 per day, benfotiamine is lipid-soluble and can safely be used at much higher levels than common vitamin B-1.
Most people get excellent results in 14-21 days time using two 150mg. capsules twice per day (two in the morning and two in the evening). Benfotiamine need not be taken with meals. Some people get better results increasing the dosage to 900mg. or 1200mg. per day after the first two weeks. The point here is that benfotiamine is safe at any reasonable daily usage level. An individual should merely find the level that produces the maximum beneficial effect without reaching a point of diminishing return beyond which the excess amount is wasted.
Dr. Brownlee participated in a clinical trial using 600mg./day: Clinical Trial Using 600mg. Daily. As for me, I noted dramatic results after increasing daily usage to 600mg. My neuropathy symptoms ceased progression and began to reverse and I experienced a complete cessation of sciatica episodes. Also, my average blood pressure dropped from a persistent 145/90 to 120/80, without the use of other blood pressure medications. I now take two capsules in the morning and two in the evening, everyday.
7. WHAT IS THE FDA POSITION ON BENFOTIAMINE?
At first I was curious as to whether benfotiamine is considered a drug or a supplement. I have established to my satisfaction (and based on the expert opinion of others in the industry) that benfotiamine, a synthetic derivative of vitamin B-1, is a dietary supplement under the Dietary Supplement Health and Education Act (DSHEA) of 1994. During 2003 I have successfully imported to the U.S. both bottled tablets as well as bulk benfotiamine, with full disclosure and full FDA and U.S. Customs review and approval at the respective U.S. ports of entry. Let me emphasize that. The FDA did a hands-on review and inspection of my imported benfotiamine, with full disclosure as to contents by both name and chemical formula, and approved all items for import. Benfotiamine may be imported under Tariff Number: 2936.22.00.00, (thiamine and its derivatives).
For those curious as to the current FDA stance on dietary supplements, I offer the following quote from their website:
"Under DSHEA, a firm is responsible for determining that the dietary supplements it manufactures or distributes are safe and that any representations or claims made about them are substantiated by adequate evidence to show that they are not false or misleading. This means that dietary supplements do not need approval from FDA before they are marketed." See: http://www.cfsan.fda.gov/~dms/ds-oview.html. As to the safety of benfotiamine, please see the data provided above in this document.
8. WHY HAVEN'T I HEARD OF BENFOTIAMINE BEFORE?
Though attempts were made by the Japanese pharmaceutical manufacturer Sankyo to market benfotiamine in the U.S. decades ago, there was little interest until the recent article published in the U.S. by Dr. Brownlee. Since that time, interest in benfotiamine has increased dramatically. I have heard some speculation that since the patent on benfotiamine expired years ago, no large company is interested in investing in its promotion. I personally remain mystified as to why this very beneficial compound has languished in obscurity in this country until now.
9. WHAT DOES "PHARMACEUTICAL GRADE" MEAN?
"Pharmaceutical grade" means that the product has been manufactured under GMP conditions and is safe, pure and effective. Under GMP (Good Manufacturing Practices) every step of the process is documented by using established SOPs (Standard Operating Procedures). This includes training, equipment, raw materials, facilities, and final release criteria. Everything can be traced back to the date, time, person, lot number, and piece of equipment used.
10. HAVE YOU RECEIVED ANY TESTIMONIALS?
Yes, I am very gratified that, like me, many others are getting good results with benfotiamine. You may read the testimonials I have received to date at this link: TESTIMONIALS.
11. WHERE CAN I BUY BENFOTIAMINE?
Please follow THIS LINK to be redirected to a website where you may order benfotiamine.
Note: If you have other questions you would like to see answered here, please email us at: info@benfotiamine.org.
(Note: Since benfotiamine is classified as a dietary supplement and not a drug, the U.S. FDA has not evaluated its effectiveness. Benfotiamine therefore cannot be represented to diagnose, treat, cure or prevent any disease. Also, the information above was assembled by a lay-person, not a medical professional nor practitioner. For medical advice, please consult your health care professional.)
[Message sent by gomarwah@gmail.com via AddThis.com.]
Dear Govind's Blog:
Govind Marwah has sent you the following link from dLife.com:
7 Self-Care Behaviors for helpful tips, videos and articles to help you manage your diabetes! Dr Marwah
dLife — For Your Diabetes Life is the number-one consumer resource that empowers millions of diabetes patients and those that care for them to live well with diabetes. dLife is your place to go for all aspects of your diabetes life — to find information, inspiration, and connection with others who share your challenges and concerns. Visit dLife.com today.
Regards,
The dLife Team
CDC H1N1 Flu | Interim Guidance for Infection Control for Care of Patients with Confirmed or Suspected Swine Influenza A (H1N1) Virus Infection in a Healthcare Setting
http://www.cdc.gov/h1n1flu/guidelines_infection_control.htm
WHO Director-General Dr. Margaret Chan said at a press briefing
Thursday that "the scientific criteria for an influenza pandemic have been
met," and that she was raising the alert level from 5 to 6 — the highest level
(denoting widespread community transmission on two continents).
"We do not expect to see a sudden and dramatic jump in the number
of severe or fatal infections," she said, but she also warned that "the virus
writes the rules."
CENTRAL GOVERNMENT EMPLOYEES NEWS |
Posted: 01 Jun 2009 05:33 PM PDT Revision of rates of subscription under Central Government Health Scheme due to revision of pay and allowance of CG employees and revision of Pension / Family Pension on account of implementation of recommendations of the 6th Central Pay Commission. Monthly Contributions for availing CGHS facility:
Entitlements of Wards in private hospitals empanelled under CGHS:
Monetary Ceiling for Free Diet:The monetary ceiling for free diet for CGHS beneficiaries is revised to Pay / Pension / Family Pension of Rs. 7,450/- per month. Monetray ceiling for free diet for beneficiaries suffering from TB or Mental Disease:The monetry ceiling for free diet in case of beneficiary suffering from TB or Mental Disease is revised to pay / pension / family pension of Rs. 11,160/- per month. Pay slab for determining the entitlement of Nursing Home facilities in Central Government / State Government / Municipal Hospitals:The monetary ceiling for determining the entitlement of nursing home faicilities in Central Government / State Government / Municipal Hospitals is revised to Pay / pension / family pension Rs. 13,950/- per month and above. Monetary ceiling for direct consultation with Specialists in Central Government / State Government / Municipal Hospitals:The monetary ceiling for determining the entitlement for direct consultation with Specialists in Central Government / State Government / Municipal Hospitals is revised to pay / pension / family pension of Rs. 33,480/- per month and above.Hospitals Pay slab for determining the entitlement of accomodation in AIIMS, New Delhi:
It is clarified that the reference to pay in this order relates to the pay drawn in the pay band. Pensioners have an option to get their CGHS pensioners card made by either making CGHS contribution on an annual basis (Twelve months) or by making contribution for 10 (ten) years [120 (one hundred and twenty) months] for getting a pensioners CGHS card with life-time validity. |
A good news for all beneficiaries of Central Government Health Scheme (CGHS), Ministry of Health & Family Welfare, Government of India has launched a new helpline number wherein you can drop your complaints and feedback.
Tel. 011-66667777
e-mail- helpline-cghs@nic.in
Beneficiaries can contact the Helpline by phone or e-mail for
CGHS Helpline operates on all working days from 9:30 A.M. to 5:30 PM.
Swine Flu: CDC Offers Clinical Guidance, WHO Raises Alert Level Again
The CDC has released a series of flu-related interim clinical guidance documents. They include one on the care of infected children and pregnant women, another for emergency medical services, and a case-definition document. With regard to infected children, the advisory says the signs of severe disease include apnea, tachypnea, dyspnea, cyanosis, dehydration, altered mental status, and extreme irritability. Pregnant women suspected of being infected "should receive empiric antiviral treatment." The CDC clarified case-definition terms as follows: WHO raised its pandemic alert level from 4 to 5 (on a 6-level scale), reflecting confirmed person-to-person spread and the imminence of the threat. Earlier on Wednesday, the CDC confirmed the first death in the U.S.
Swine influenza (also swine flu) refers to influenza caused by any strain of the influenza virus endemic in pigs (swine). Strains endemic in swine are called swine influenza virus (SIV).
Swine flu is common in swine and rare in humans. People who work with swine, especially people with intense exposures, are at risk of catching swine influenza if the swine carry a strain able to infect humans. However, these strains rarely are able to pass from human to human. Rarely, SIV mutates into a form able to pass easily from human to human. The strain responsible for the 2009 swine flu outbreak is believed to have undergone such a mutation.This virus is named swine flu because one of its surface proteins is similar to viruses that usually infect pigs however this strain is spreading in people and it is unknown if it infects pigs.
In humans, the symptoms of swine flu are similar to those of influenza and of influenza-like illness in general, namely chills, fever, sore throat, muscle pains, severe headache, coughing, weakness and general discomfort. The strain responsible for the 2009 swine flu outbreak in most cases causes only mild symptoms and the infected person recovers fully in a few days.
Of the three genera of human flu, two are endemic also in swine: Influenzavirus A (common) and Influenzavirus C (rare). Influenzavirus B has not been reported in swine. Within Influenzavirus A and Influenzavirus C, the strains endemic to swine and humans are largely distinct.
The CDC recommends the use of Tamiflu (oseltamivir) or Relenza (zanamivir) for the treatment and/or prevention of infection with swine influenza viruses. The virus isolates that have been tested from the US and Mexico are however resistant to amantadine and rimantadine. If a person gets sick, antiviral drugs can make the illness milder and make the patient feel better faster. They may also prevent serious flu complications. For treatment, antiviral drugs work best if started soon after getting sick (within 2 days of symptoms).
The following Diagnostic Centers have been empaneled under CGHS with effect from 1st November, 2006, and thereafter, for the purposes specified:-
Delhi: (25/02/2009)
Diagnostic Centers
| Central Delhi Diagnostic & Research Centre, New Delhi | laboratory services [Laboratory services depanelled w.e.f. 24.09.2008]. |
| Chetna's Pathlab, M-26, Basement, Chitranjan Park, New Delhi | laboratory services [Laboratory services depanelled w.e.f. 24.09.2008]. |
| City X ray and scan clinic (P) Ltd., Tilak Nagar, New Delhi | Laboratory services, CT scan, USG/Colour Doppler, Bone Densitometry, ECG, TMT, X-ray and mammography (Not recognised for MRI). |
| City X ray and scan clinic (P) Ltd., Vikas Puri, New Delhi | Laboratory services, CT scan, mammography, USG/Colour Doppler and X-Ray. |
| Delhi Heart Hospital, 176, Jagriti Enclave, Vikas Marg Extn., Delhi | Laboratory services and cardiological investigation (colour Doppler, echo cardiography, TMT, Holter and PFT). |
| Delhi Institute for Functional Imaging, K-16, South Ex., Part –I, New Delhi | Diagnostic centre for nuclear medicine |
| Delhi MRI and CT scan Centre, Aashlok Hospital, 25-A, Block AB, Community Center, Safdarjung Enclave, New Delhi [Now known as Piramal Diagnostic Services – Delhi MR & CT Aashlok Hospital, 25 A Block AB, Community Centre, Safdarjung Enclave, New Delhi 110 029] | CT scan and Ultrasonography only. |
| Delhi MRI Scan Centre, M-2, Hauz Khas, New Delhi [Now known as Piramal Diagnostic Services – Delhi MRI, M 2 Hauz Khas, Aurobindo Marg, Near ABN Amro Bank, New Delhi 110 016]. | MRI, X-ray, Bone Densitometry, |
| Dewan Chand Satypal Aggarwal Imaging & Research Centre, 10-B, K.G. Marg, New Delhi (Tel: 2332 9887; 2321 6327) | Radiological diagnosis and imaging services (MRI, CT scan, Mammography, USG/Colour Doppler, X-ray, Bone Densitometry). |
| Dr. A Lal Chandani Pathology Laboratories, J-36, Lajpat Nagar-II, New Delhi | Laboratory services |
| Dr. Anand Imaging & Neurological Research Centre, G-14, Preet Vihar, Vikas Marg, Delhi – 92 | Imaging services including MRI, CT scan, Ultrasonography / Colour Doppler, X ray and mammography. . |
| Dr. Handa X-ray & Imaging Centre, B-87, Diffence Colony, New Delhi | USG services only. |
| Dr. M.L Aggarwal X-Ray & Ultrasound Clinic, A-1/150, Safdarjang Enclave, New Delhi. | X-ray, Ultrasonography and colour Doppler imaging services |
| Dr. Mittal Diagnostic centre, Madhuban Chowk, Main Outer Ring Road, 611/C-8, Sector-VIII, Rohini, Delhi | Laboratory services, USG/Colour Doppler and X-ray. [Laboratory services depanelled w.e.f. 24.09.2008]. |
| Dr. P. Bhasin Path Labs (P) Ltd., S-13, Greater Kailash, Part-I, New Delhi | Diagnostic procedures in Laboratory services |
| Dr. S.S. Doda's Ultrasound Centre, 23-B, Pusa Road, New Delhi, Delhi | CT, Mammography, USG/Colour Doppler, X-ray. |
| Dr. Savita Jain's Arun Imaging Centre, D-29, Vivek Vihar, Delhi | Diagnostic centre for USG / colour Doppler, Echo mammography, Bone densitometry, X-Ray, ECG, TMT and Holter |
| Faridabad CT Scan Centre at Escort Hospital & Research Centre, Neelam Chowk, Faridabad | CT scan and EEG. |
| Final Diagnosis Centre, C-1/2, Sector-31, Noida. | Laboratory services, Ultrasonography and Mammography. |
| First Dwarka Lab, 185, Sector-6, Pocket-I, Dwarka, New Delhi | Laboratory services |
| Focus Imaging and Research Centre, C-10, Green Park Extn., New Delhi | USG / Colour Doppler, CT scan, Mammography, Bone densitometry and X-Ray |
| Focus Imaging and Research Centre, 47/1-2, Yusuf Sarai Market, Aurobindo Marg, New Delhi | Diagnostic services in MRI |
| Ganesh Diagnostic and Imaging Centre Pvt. Ltd., Pocket-A-1, Plot No.109, Sector-8, Rohini, New Delhi | Laboratory services and Imaging- MRI, CT scan, USG/Colour Doppler and X-ray. |
| GMR Institute of Imaging Research, A-13, Green Park Main, Aurbindo Marg, New Delhi | MRI, CT scan, USG / Colour Doppler, X-ray, Bone densitometry and Mammography. [Referrals to the Institute stopped] |
| Goyal MRI and Diagnostic Centre, B-1/12, Safdarjung Enclave, New Delhi | Laboratory services and imaging services in MRI and USG/ Colour Doppler. |
| Green Park Diagnostics, (1st Floor), G-43, Green Park, Main Market, New Delhi | Laboratory services |
| India IVF Centre and Research Institute, 17-A, Lajpat Nagar-IV, New Delhi | Diagnostic centre for USG / colour Doppler, ECG, TMT and Holter. |
| Janta X-ray and Clinical Lab, WZ-4, Raja Garden, Delhi | Laboratory services and imaging viz CT scan, mammography, USG/ Colour Doppler. [Laboratory services depanelled w.e.f. 24.09.2008]. |
| JDAR Pathology Lab, 2/6, Shanti Niketan, New Delhi | Clinical pathology and Clinical Biochemistry. |
| Krystal Scan and Diagnostic Centre, 1, Paschimi Enclave, Rohtak Road, Peeragarhi Crossing, New Delhi. | Laboratory services, MRI, CT scan, USG and X-ray. [Laboratory services depanelled w.e.f. 24.09.2008]. |
| Life Line Laboratory, H-11, Green Park Extention, New Delhi | Laboratory services |
| M/S Janta Diagnostic Centre, Sunder Vihar, 12/404, Sunder Vihar Paschim Vihar, New Delhi | Laboratory services, CT, mammography, USG/Colour Doppler, ECG, ECHO [Laboratory services depanelled w.e.f. 24.09.2008]. |
| Mahajan Imaging Centre, K-18, Hauz Khas Enclave, New Delhi | MRI, CT scan, USG/Colour Doppler, mammography, X-ray and Bone Densitometry. |
| Mahajan Imaging Centre | CT scan, Bone Densitometry and USG |
| Mahajan Nuclear Medicine and Bone Densitometry (Sir Ganga Ram Hospital), Delhi | Diagnostic Imaging Services (Bone densitometry and nuclear medicine) |
| Modern Diagnostic & Research Center, 363/4, New Railway Road, Gurgaon | Laboratory services, CT scan, mammography, colour Doppler / USG, X-ray and Bone densitometry |
| National CT Scan & Diagnostic Centre, 17, NWA, Club Road, Punjabi Bagh, New Delhi | Laboratory services, USG, Bone densitometry, X-ray and CT scan. |
| NMC Imaging Centre (VIMHANS), 1, Institutional Area, Nehru Nagar, New Delhi | Laboratory services, MRI, CT scan and X-ray [Laboratory services depanelled w.e.f. 24.09.2008]. |
| Noble Diagnostic Centre, WZ-409-C, Janak Park, Opp. DDU Hospital, Hari Nagar, New Delhi | X-ray and Ultrasonography. |
| North MR Scan Research Institute (Sir Ganga Ram Hospital) Old Rajinder Nagar, New Delhi | MRI |
| Organ Imaging Research Centre, A-23, Green Park, New Delhi | MRI, CT scan, X-ray and Bone densitometry. |
| Pathlab, D-87-A, East of Kailash, New Delhi | Laboratory services [[Laboratory services depanelled w.e.f. 24.09.2008]. |
| Saral Advanced Diagnostic Pvt. Ltd., E-1073, Saraswati Vihar, Pitam Pura, Delhi | Laboratory services, USG / colour Doppler, Mammography, CT scan, X-Ray, Bone Densitometry, Nuclear Medicine and diagnostic centre (MRI). |
| South Delhi Ultrasound & X-Ray Clinic, A-44, Hauz Khas, New Delhi. | Ultrasound /Colour Doppler, OPG and Mammography |
| Star Imaging and Path Lab, 4B/4, Tilak Nagar, New Delhi | Laboratory services, CT scan, Ultrasonography/ colour Doppler, X-ray and Bone densitometry. |
| Sun Imaging Centre, 15, Hargovind Enclave, Vikas Marg Extn., Delhi | MRI, CT scan, USG/ Colour Doppler and Bone densitometry |
| Suvidha Diagnostic Center, C-105, Mandwali, Patpar Ganj Society Complex, Opp. I.P. Extn. Delhi. | Laboratory services, X-ray and USG/Colour Doppler. [Laboratory services depanelled w.e.f. 24.09.2008]. |
| The Apollo Clinic, Krishna Bhawan, 7-8, A-3, Shopping Center, Near St. Marg School, Janakpuri, New Delhi | Laboratory services (in Clinical Pathology and Clinical Biochemistry) and Ultrasonography. [Laboratory services depanelled w.e.f. 24.09.2008]. |
| The Apollo Clinic, B-4, Sector-16, NOIDA | Laboratory services, USG/Colour Doppler [Empanelment cancelled w.e.f. 24.09.2008]. |
| The Clinical Laboratory, E-13/9, Vasant Vihar, New Delhi | Laboratory services |
| Vasant Vision Ultrasound with Colour Doppler & X-Ray Clinic, F-9/4, Vasant Vihar, New Delhi | Ultrasonography and X-ray. |
| VGS Imaging and Diagnostics, (Escort Hospital & Research Centre), Neelam Bata Chowk, Faridabad. | Bone densitometry and Mammography. |
| Vrinda Diagnostic Centre, IIIrd, 3-9, Nehru Nagar, Ghaziabad | Laboratory services, CT, USG/Colour Doppler, Bone densitometry and X-Ray (Not recognised for MRI). [Laboratory services depanelled w.e.f. 24.09.2008]. |
| Pathnet India Pvt. Ltd., Plot 31, Sector 18, Udyog Nagar, Gurgoan | Laboratory services(w.e.f 3rd November 2006) |
| Dr. Lal Path Labs Pvt. Ltd., Eskay House, 54 Hanuman Road, New Delhi | Laboratory (Clinical pathology, Biochemistry and Microbiology) |
56 | Batra Hospital & Medical Research Centre, 1 Tughlakabad Institutional Area, Mehrauli Badarpur Road, New Delhi 110 062. | Diagnostic services (Laboratory, X-Ray, CT Scan, USG, Colour Doppler, MRI). [Empanelment of the hospital cancelled w.e.f. 16.01.2009]. |
57 | Apollo Clinic [licensee Bharti Medicare (P) Ltd.], C 70, Major Sudesh Kumar Marg, Opp. Madhav Park, New Delhi. | Diagnostic services (Laboratory, USG / Colour Doppler, X-Ray, TMT, FFT, ECG and Echo). (AERB approval for X-Ray is not available.) |
58. | Dr. Khanna's Pathcare Pvt. Ltd., A 43 Hauz Khas, New Delhi. | Laboratory (Clinical pathology, Biochemistry and Microbiology) |
59. | Focus Imaging & Research Centre, IHBAS Complex, Dilshad Garden, Delhi. | Diagnostic centre (MRI) |
60. | Nanda Diagnostic Centre, ED 9A, Madhuban Chowk, Pitampura, Delhi | Laboratory (Clinical pathology and Biochemistry), USG/Colour Doppler, X-Ray, Bone Densitometry. [[Laboratory services depanelled w.e.f. 24.09.2008]. |
61 | Dr. S. B. Gandhi Diagnostic Centre, A 2/ 152 Janakpuri, New Delhi 110 058 | Diagnostic services (USG / Colour Doppler). |
62 | Star Imaging & Path Lab., 4 B / 4 Tilak Nagar, New Delhi 110 018 | Diagnostic Centre (MRI). |
63 | Dr. Makashir's Diagnostic Medical Lab Pvt. Ltd., 1/4 Vikram Vihar, Lajpat Nagar IV, [Opp. Haldiram] New Delhi 110 024 [Tel: 011 – 2622 2458 / 2646 3080] | Diagnostic centre [Clinical Pathology; Biochemistry & Microbiology] |
64 | Unipath Diagnostic, G-49, Lajpat Nagar II, New Delhi 110 024 [Tel: 93122 77338] | Diagnostic Centre [Clinical Pathology, Biochemistry, Microbiology and USG / Colour Doppler]. |
65 | Focus Imaging & Research Centre Pvt. Ltd., H 10 Green Park Extension, New Delhi 110016 [Tel: 011 – 4219 9993] | Diagnostic purposes [MRI, CT, EEG, EMG and NCV]. |
66 | Clinical Diagnostic Centre, 69 Hargovind Enclave, Karkardooma, Delhi 110 092 | Diagnostic purposes [Laboratory, CT, USG / Colour Doppler and X – Ray]]. |
67 | Srivastava MRI & Imaging Centre, Shop Nos. 1, 2, 3, & 6, Purvanchal Plaza, Pocket B, LSC Market, Mayur Vihar Phase 2, Delhi 110 091 | MRI and USG / Colour Doppler. |
68 | Dr. P. Bhasin Pathlabs Pvt. Ltd., S 13, Greater Kailash Part I, New Delhi. | Diagnostic centre [USG / Colour Doppler, Bone Densitometry, Echocardiography, TMT, PFT and Uroflowmetry]. |
Hosted by eSnips |